JP2024505515A5 - - Google Patents
Info
- Publication number
- JP2024505515A5 JP2024505515A5 JP2023545765A JP2023545765A JP2024505515A5 JP 2024505515 A5 JP2024505515 A5 JP 2024505515A5 JP 2023545765 A JP2023545765 A JP 2023545765A JP 2023545765 A JP2023545765 A JP 2023545765A JP 2024505515 A5 JP2024505515 A5 JP 2024505515A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical product
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163142876P | 2021-01-28 | 2021-01-28 | |
| US63/142,876 | 2021-01-28 | ||
| US202163196902P | 2021-06-04 | 2021-06-04 | |
| US63/196,902 | 2021-06-04 | ||
| PCT/EP2022/052131 WO2022162193A1 (en) | 2021-01-28 | 2022-01-28 | Methods for the treatment of childhood-onset fluency disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024505515A JP2024505515A (ja) | 2024-02-06 |
| JP2024505515A5 true JP2024505515A5 (https=) | 2025-02-04 |
Family
ID=81235223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545765A Pending JP2024505515A (ja) | 2021-01-28 | 2022-01-28 | 小児期発症流暢症の治療のための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230381193A1 (https=) |
| EP (1) | EP4284381A1 (https=) |
| JP (1) | JP2024505515A (https=) |
| KR (1) | KR20230171918A (https=) |
| AU (1) | AU2022214289A1 (https=) |
| CA (1) | CA3206573A1 (https=) |
| CL (1) | CL2023002192A1 (https=) |
| IL (1) | IL304599A (https=) |
| MX (1) | MX2023008796A (https=) |
| WO (1) | WO2022162193A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12544364B2 (en) | 2020-06-05 | 2026-02-10 | Noema Pharma Ag | Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030032579A1 (en) * | 2001-04-20 | 2003-02-13 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
| US8349824B2 (en) * | 2010-12-07 | 2013-01-08 | Hoffmann-La Roche Inc. | Triazolopyridine compounds |
| MY169128A (en) * | 2013-04-30 | 2019-02-18 | Hoffmann La Roche | Pd-catalyzed coupling of pyrazole amides |
| CN116137811B (zh) * | 2020-06-05 | 2026-01-09 | 诺埃玛制药公司 | 用于治疗杜尔雷斯综合征的磷酸二酯酶10抑制剂的用途 |
-
2022
- 2022-01-28 WO PCT/EP2022/052131 patent/WO2022162193A1/en not_active Ceased
- 2022-01-28 AU AU2022214289A patent/AU2022214289A1/en active Pending
- 2022-01-28 CA CA3206573A patent/CA3206573A1/en active Pending
- 2022-01-28 JP JP2023545765A patent/JP2024505515A/ja active Pending
- 2022-01-28 EP EP22704885.7A patent/EP4284381A1/en active Pending
- 2022-01-28 KR KR1020237029194A patent/KR20230171918A/ko active Pending
- 2022-01-28 MX MX2023008796A patent/MX2023008796A/es unknown
-
2023
- 2023-07-19 IL IL304599A patent/IL304599A/en unknown
- 2023-07-25 CL CL2023002192A patent/CL2023002192A1/es unknown
- 2023-07-27 US US18/360,533 patent/US20230381193A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI898177B (zh) | 化合物之調配物及其用途 | |
| JP2022537551A5 (https=) | ||
| JP2022535893A5 (https=) | ||
| WO2015185011A1 (zh) | 喹啉衍生物用于治疗甲状腺癌的方法和用途以及用于治疗甲状腺癌的药物组合物 | |
| JP5362151B2 (ja) | Ｐｇｄ２拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬 | |
| WO2017118401A1 (zh) | 喹啉衍生物用于治疗食管癌的用途及其治疗方法、药物组合物和试剂盒 | |
| JP2022508513A5 (https=) | ||
| AU2021255084B2 (en) | Breast cancer therapeutic agent | |
| JP2023528896A5 (https=) | ||
| JP2024505515A5 (https=) | ||
| CN101747305A (zh) | 硝克柳胺化合物五种晶型、其制法和其药物组合物与用途 | |
| JP2025533719A (ja) | がんの治療のためのｋａｔ６阻害剤を含む投与レジメン | |
| CN113876775B (zh) | 一种青藤碱或其药物可接受的盐作为治疗动脉性肺动脉高压药物的用途 | |
| CN101898962B (zh) | 大黄酸晶b型固体物质及制备方法与用途 | |
| CN100418526C (zh) | 依贝沙坦在制备用来预防或治疗肺动脉高压的药物中的应用 | |
| CN117412751A (zh) | 用于预防或治疗肺纤维化的药物制剂 | |
| WO1996011682A1 (en) | Preventive and remedy for type i allergic diseases | |
| JP4614640B2 (ja) | 解熱剤組成物 | |
| TW200911247A (en) | Use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for preparing a medicament for use in the treatment of motor disorders related to parkinson's disease | |
| ES2899885T3 (es) | Nueva composición farmacéutica de liberación diferencial que contiene tres principios activos | |
| CN100372533C (zh) | 腹泻为主大肠激惹综合征的治疗制剂 | |
| JP2022524819A (ja) | カプシド集合調節剤固体製剤 | |
| TW201806599A (zh) | 用於快速開始抗抑鬱作用之給藥方案 | |
| JP2025507219A (ja) | がんを処置するためのイバルチノスタット（ｉｖａｌｔｉｎｏｓｔａｔ）の使用 | |
| CN101663036B (zh) | 4-环丙基甲氧基-n-(3,5-二氯代-1-氧代-4-吡啶-4-基)-5-(甲氧基)吡啶-2-甲酰胺用于治疗颅脑创伤的用途 |